At the time of writing, Abbvie Inc [ABBV] stock is trading at $206.27, down -1.55%. An important factor to consider is whether the stock is rising or falling in short-term value. The ABBV shares have gain 2.45% over the last week, with a monthly amount drifted -2.46%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Daiwa Securities downgraded its rating to Neutral on December 05, 2024, and kept the price target unchanged to $180. On November 22, 2024, upgrade upgraded it’s rating to Outperform but maintained its price target of $206 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $205 on November 15, 2024. Argus upgraded its rating to a Buy. Bernstein started tracking with a Mkt Perform rating for this stock on October 17, 2024, and assigned it a price target of $203. In a note dated June 05, 2024, HSBC Securities upgraded an Buy rating on this stock but restated the target price of $185.
For the past year, the stock price of Abbvie Inc fluctuated between $153.58 and $218.66. Currently, Wall Street analysts expect the stock to reach $214.8 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $206.27 at the most recent close of the market. An investor can expect a potential return of 4.14% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
According to Abbvie Inc [NYSE:ABBV], the company’s sales were 56.33B for trailing twelve months, which represents an 5.60% jump. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.71 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of20.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 203.86 points at the first support level, and at 201.46 for the second support level. However, for the 1st resistance point, the stock is sitting at 210.41, and for the 2nd resistance point, it is at 214.56.
Ratios To Look Out For
It is important to note that Abbvie Inc [NYSE:ABBV] has a current ratio of 0.66. On the other hand, the Quick Ratio is 0.55, and the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 6.48, the price to book ratio is 109.51 and price to earnings (TTM) ratio is 86.25.
Transactions by insiders
Recent insider trading involved Stewart Jeffrey Ryan, Officer, that happened on Mar 31 ’25 when 58832.0 shares were purchased. EVP, CHIEF FINANCIAL OFFICER, Reents Scott T completed a deal on Mar 14 ’25 to sell 17644.0 shares. Meanwhile, Officer Reents Scott T bought 17644.0 shares on Mar 14 ’25.
